RxDoctor Payments Data

Scott Clark, DPM

Foot & Ankle Surgery · West Jordan, UTNPI 1700865748

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $61,661 of the $74,398 with a category attached, or 82.9%. Orthofix Medical, Inc. accounts for 98.7% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2024 at $19,529 and has fallen 78.0% since, to $4,294 in 2025. Among foot & ankle surgery clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$74,398in general payments, 2019–2025

Across 179 payments — averaging $415.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Orthofix Medical, Inc.$73K
  • Treace Medical Concepts, Inc.$329
  • Stryker$189
  • Integra Lifesciences Corporation$110
  • Medtronic$87
  • Melinta Therapeutics, LLC$76
  • plus $188 from 7 others
$3,902in research payments, 2019–2025

Across 1 payment — averaging $3902.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bristol Myers Squibb$4K

What the payments were for

  • Consulting fees$61,66183%
  • Travel & lodging$10,01213%
  • Food & beverage$2,7254%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$74,398 in reported general payments places this provider in the 90th percentile of 104 foot & ankle surgery providers in Utah.

See all foot & ankle surgery providers in Utah

Medicare billing

Part B allowed, 2024
$66,700
Medicare patients
170
Services billed
959

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin33$609
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav15$189
SsdSilver Sulfadiazine18$183
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim12$127
Meloxicam25$124

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in West Jordan

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →